342 related articles for article (PubMed ID: 20716168)
21. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
22. [Expression of CD117, CD34, SMA, S-100 protein, Vim and desmin in patients with gastrointestinal stromal tumors].
Liu J; Liu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):438-40. PubMed ID: 18359707
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumours at the University of Nigeria Teaching Hospital Enugu, Nigeria: an immunohistochemical study of GIT mesenchymal tumours.
Ezeome ER; Olusina DB; Igbokwe UO
Niger J Clin Pract; 2010 Sep; 13(3):306-10. PubMed ID: 20857791
[TBL] [Abstract][Full Text] [Related]
25. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
26. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
[TBL] [Abstract][Full Text] [Related]
27. DOG1 immunoreactivity in uterine leiomyosarcomas.
Sah SP; McCluggage WG
J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical diagnosis of gastrointestinal stromal tumors - an analysis of 80 cases from 2004 to 2010.
Kiśluk J; Gryko M; Guzińska-Ustymowicz K; Kemona A; Kędra B
Adv Clin Exp Med; 2013; 22(1):33-9. PubMed ID: 23468260
[TBL] [Abstract][Full Text] [Related]
29. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
31. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
32. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
34. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
35. Gastro-intestinal stromal tumour--role of CD117 in diagnosis and management.
Paul PC; Chakraborty J; Kundu D; Sarkar R
Indian J Pathol Microbiol; 2007 Apr; 50(2):279-83. PubMed ID: 17883045
[TBL] [Abstract][Full Text] [Related]
36. DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration.
Fatima N; Cohen C; Siddiqui MT
Cancer Cytopathol; 2011 Jun; 119(3):202-8. PubMed ID: 21400668
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumours--an update for histopathologists.
Wong NA
Histopathology; 2011 Nov; 59(5):807-21. PubMed ID: 21668468
[TBL] [Abstract][Full Text] [Related]
38. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
39. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
Gutierrez MR; Dorronsoro ML; Marco AM; Pérez IR; Villegas IA; Virseda JM
An Sist Sanit Navar; 2011; 34(2):245-51. PubMed ID: 21904406
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
